Cargando…

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes

The splicing factor SF3B1 is the most frequently mutated gene in myelodysplastic syndromes (MDS), and is strongly associated with the presence of ring sideroblasts (RS). We have performed a systematic analysis of cryptic splicing abnormalities from RNA sequencing data on hematopoietic stem cells (HS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dolatshad, H, Pellagatti, A, Liberante, F G, Llorian, M, Repapi, E, Steeples, V, Roy, S, Scifo, L, Armstrong, R N, Shaw, J, Yip, B H, Killick, S, Kušec, R, Taylor, S, Mills, K I, Savage, K I, Smith, C W J, Boultwood, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029572/ https://www.ncbi.nlm.nih.gov/pubmed/27211273 http://dx.doi.org/10.1038/leu.2016.149

Ejemplares similares

The U2AF1(S34F) mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
por: Yip, Bon Ham, et al.
Publicado: (2017)

Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
por: Dolatshad, H, et al.
Publicado: (2015)

Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
por: Dolatshad, H, et al.
Publicado: (2015)

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)
por: Bello, Erica, et al.
Publicado: (2015)

Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
por: Gerstung, Moritz, et al.
Publicado: (2015)

Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability
por: Liberante, Fabio Giuseppe, et al.
Publicado: (2019)

Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
por: Choudhary, Gaurav S, et al.
Publicado: (2022)

The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts
por: Boultwood, Jacqueline, et al.
Publicado: (2008)

SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications
por: Singh, Shalini, et al.
Publicado: (2020)

Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression
por: Pellagatti, A, et al.
Publicado: (2016)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
por: Malcovati, Luca, et al.
Publicado: (2011)

ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts
por: Valletta, Simona, et al.
Publicado: (2015)

Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome
por: Clough, Courtnee A., et al.
Publicado: (2022)

Recent Advances in the 5q- Syndrome
por: Pellagatti, Andrea, et al.
Publicado: (2015)

The impact of spliceosome mutations in MDS
por: Boultwood, Jacqueline, et al.
Publicado: (2019)

Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
por: Lappin, Katrina M., et al.
Publicado: (2022)

The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome
por: Rujirachaivej, Punchita, et al.
Publicado: (2018)

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
por: Scharenberg, Christian, et al.
Publicado: (2017)

SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity
por: Mangaonkar, Abhishek A., et al.
Publicado: (2022)

SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast
por: Carrocci, Tucker J., et al.
Publicado: (2017)

Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes
por: Pellagatti, Andrea, et al.
Publicado: (2008)

Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers
por: DeBoever, Christopher, et al.
Publicado: (2015)

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes
por: Mongiorgi, Sara, et al.
Publicado: (2023)

Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics
por: Fernandez-Mercado, Marta, et al.
Publicado: (2012)

Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia
por: Gregers, J, et al.
Publicado: (2015)

A Case of SF3B1-Positive Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis
por: Lazo-Langner, Alejandro, et al.
Publicado: (2019)

A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation
por: Ma, Liya, et al.
Publicado: (2022)

Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia
por: Liberante, Fabio Giuseppe, et al.
Publicado: (2015)

SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes
por: Lieu, Yen K., et al.
Publicado: (2021)

GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome
por: Botezatu, Lacramioara, et al.
Publicado: (2016)

Alteration of SF3B1 and SRSF2 Genes in Myelodysplastic Syndromes Patients in Upper Northern Thailand
por: Yimpak, Phuttirak, et al.
Publicado: (2019)

Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome
por: Ochi, Tetsuro, et al.
Publicado: (2022)

Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts
por: Mangaonkar, Abhishek A., et al.
Publicado: (2018)

Cancer associated SF3B1 mutants recognize otherwise inaccessible cryptic 3’ splice sites within RNA secondary structures
por: Kesarwani, Anil K., et al.
Publicado: (2016)

Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia
por: Bajaj, Renu, et al.
Publicado: (2011)

SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process
por: Jiang, Moqin, et al.
Publicado: (2023)

ABCB1 in dermatology: roles in skin diseases and their treatment
por: Weng, H. J., et al.
Publicado: (2021)

Splicing factor SF3B1 mutations and ring sideroblasts in myelodysplastic syndromes: a Brazilian cohort screening study
por: Donaires, Flávia Sacilotto, et al.
Publicado: (2016)

Detergent Screening and Purification of the Human Liver ABC Transporters BSEP (ABCB11) and MDR3 (ABCB4) Expressed in the Yeast Pichia pastoris
por: Ellinger, Philipp, et al.
Publicado: (2013)

Cryptic e1a2 BCR-ABL1 Fusion With Complex Chromosomal Abnormality in de novo Myelodysplastic Syndrome
por: Seo, Bo-Young, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qq4eo649g4r3s5bekm84uavk0u